# OnCo record paper-topaz-1-lancet-gastroenterol-hepatol-2024-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-topaz-1-lancet-gastroenterol-hepatol-2024-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-topaz-1-lancet-gastroenterol-hepatol-2024-update" ;
  schema:name "Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study"@en ;
  schema:description "Later report from the TOPAZ-1 trial registered as NCT03875235, in The lancet. Gastroenterology & hepatology (2024); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-topaz-1-lancet-gastroenterol-hepatol-2024-update/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s2468-1253(24)00095-5>, <https://pubmed.ncbi.nlm.nih.gov/38823398/>, <https://europepmc.org/article/MED/38823398>, <https://clinicaltrials.gov/study/NCT03875235> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s2468-1253(24)00095-5> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Oh DY, He AR, Bouattour M, et al." ;
  onco:trials <https://onco.cc/trials/topaz-1/> .